Akoya Biosciences Revenue and Competitors

Location

$83.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Akoya Biosciences's estimated annual revenue is currently $51.7M per year.(i)
  • Akoya Biosciences's estimated revenue per employee is $159,475
  • Akoya Biosciences's total funding is $83.5M.
  • Akoya Biosciences's current valuation is $461.7M. (January 2022)

Employee Data

  • Akoya Biosciences has 324 Employees.(i)
  • Akoya Biosciences grew their employee count by -15% last year.

Akoya Biosciences's People

NameTitleEmail/Phone
1
Regional VP Sales, North AmericaReveal Email/Phone
2
CMO SpecialistReveal Email/Phone
3
VP Translational & Scientific AffairsReveal Email/Phone
4
VP, Global Commercial OperationsReveal Email/Phone
5
SVP R&D & Laboratory OperationsReveal Email/Phone
6
VP OperationsReveal Email/Phone
7
VP, Asia PacificReveal Email/Phone
8
VP Precision MedicineReveal Email/Phone
9
VP Research And DevelopmentReveal Email/Phone
10
VP Precision MedicineReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Akoya Biosciences?

Akoya Biosciences is developing a novel high-parameter tissue analysis platform, at an order of magnitude beyond what is currently possible. Our CODEX (TM) (CO-Detection by indEXing) system enables deep proteomic profiling...all on your existing microscope. If you are a scientist or software engineer interested in revolutionizing the science of imaging, then Akoya is the place for you. Contact is at info@akoyabio.com.

keywords:N/A

$83.5M

Total Funding

324

Number of Employees

$51.7M

Revenue (est)

-15%

Employee Growth %

$461.7M

Valuation

N/A

Accelerator

Akoya Biosciences News

2022-04-20 - Akoya Biosciences Announces Ehab A. El-Gabry, MD, as ...

Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer. Published: Apr 19, 2022. MARLBOROUGH, Mass., April 19, 2022 (GLOBE NEWSWIRE)...

2022-04-17 - iCura given CRO status by Akoya Biosciences

April 18, 2022 -- iCura Diagnostics was named a fully qualified contract research organization (CRO) by Akoya Biosciences. iCura provides diagnostic testing...

2022-04-06 - Akoya Biosciences to Showcase New Data on PhenoCycler ...

MARLBOROUGH, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®,...

2021-04-01 - SITC Announces Two Spatial Technology Awards for Early Career Scientists to Advance Cancer Immunotherapy Research

Society for Immunotherapy of Cancer “SITC views these two unique technology awards as an investment in the future of our field that we hope will lead to innovative and cutting-edge immunotherapy approaches and ultimately better outcomes for patients,” said SITC President Patrick Hwu, MD... MILW ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M329-17%N/A
#2
$57.7M343-14%$225.1M
#3
$102.1M36317%$80.1M
#4
$86M382N/AN/A
#5
$63.2M38367%$106.3M